The critical role of the Hedgehog (Hh) signalling pathway in maintaining stemness in trastuzumab-resistant HER2-positive breast cancer cell lines was highlighted by this study, suggesting that targeting this pathway could be a promising strategy to overcome resistance and enhance the efficacy of existing therapies. This evidence concerns the gene ERBB2 and breast cancer.